C. ANN MERRIFIELD - 13 May 2022 Form 4 Insider Report for Lyra Therapeutics, Inc. (LYRA)

Role
Director
Signature
/s/ Jason Cavalier, Attorney-in-Fact for C. Ann Merrifield
Issuer symbol
LYRA
Transactions as of
13 May 2022
Net transactions value
+$18,486
Form type
4
Filing time
17 May 2022, 17:35:28 UTC
Previous filing
19 Nov 2021
Next filing
13 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LYRA Common Stock Purchase $16,846 +3,500 +100% $4.81 7,000 13 May 2022 Direct
transaction LYRA Common Stock Purchase $1,640 +328 +4.7% $5.00 7,328 16 May 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit 24 - Power of Attorney